These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

463 related items for PubMed ID: 9832261

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3. Immunization with the Entamoeba histolytica surface metalloprotease EhMSP-1 protects hamsters from amebic liver abscess.
    Roncolato EC, Teixeira JE, Barbosa JE, Zambelli Ramalho LN, Huston CD.
    Infect Immun; 2015 Feb; 83(2):713-20. PubMed ID: 25452550
    [Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5. The future for vaccine development against Entamoeba histolytica.
    Quach J, St-Pierre J, Chadee K.
    Hum Vaccin Immunother; 2014 Feb; 10(6):1514-21. PubMed ID: 24504133
    [Abstract] [Full Text] [Related]

  • 6. Immunogenicity of the recombinant serine rich Entamoeba histolytica protein (SREHP) amebiasis vaccine in the African green monkey.
    Stanley SL, Blanchard JL, Johnson N, Foster L, Kunz-Jenkins C, Zhang T, Tian K, Cogswell FB.
    Vaccine; 1995 Jul; 13(10):947-51. PubMed ID: 7483769
    [Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9. Host Protective Mechanisms to Intestinal Amebiasis.
    Uddin MJ, Leslie JL, Petri WA.
    Trends Parasitol; 2021 Feb; 37(2):165-175. PubMed ID: 33502317
    [Abstract] [Full Text] [Related]

  • 10. Opportunities and obstacles in developing a vaccine for Entamoeba histolytica.
    Miller-Sims VC, Petri WA.
    Curr Opin Immunol; 2002 Oct; 14(5):549-52. PubMed ID: 12183151
    [Abstract] [Full Text] [Related]

  • 11. Antigenicity, immunogenicity and vaccine efficacy of the galactose-specific adherence protein of Entamoeba histolytica.
    Ravdin JI, Shain DC, Kelsall BL.
    Vaccine; 1993 Oct; 11(2):241-6. PubMed ID: 8438621
    [Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13. Protection in a gerbil model of amebiasis by oral immunization with Salmonella expressing the galactose/N-acetyl D-galactosamine inhibitable lectin of Entamoeba histolytica.
    Mann BJ, Burkholder BV, Lockhart LA.
    Vaccine; 1997 Oct; 15(6-7):659-63. PubMed ID: 9178467
    [Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16. Optimizing a Multi-Component Intranasal Entamoeba Histolytica Vaccine Formulation Using a Design of Experiments Strategy.
    Abhyankar MM, Orr MT, Kinsey R, Sivananthan S, Nafziger AJ, Oakland DN, Young MK, Farr L, Uddin MJ, Leslie JL, Burgess SL, Liang H, De Lima I, Larson E, Guderian JA, Lin S, Kahn A, Ghosh P, Reed S, Tomai MA, Pedersen K, Petri WA, Fox CB.
    Front Immunol; 2021 Oct; 12():683157. PubMed ID: 34248966
    [Abstract] [Full Text] [Related]

  • 17. Evaluation of the PEΔIII-LC3-KDEL3 Chimeric Protein of Entamoeba histolytica-Lectin as a Vaccine Candidate against Amebic Liver Abscess.
    Martínez-Hernández SL, Becerra-González VM, Muñoz-Ortega MH, Loera-Muro VM, Ávila-Blanco ME, Medina-Rosales MN, Ventura-Juárez J.
    J Immunol Res; 2021 Oct; 2021():6697900. PubMed ID: 33824880
    [Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20. Intranasal immunization with Gal-inhibitable lectin plus an adjuvant of CpG oligodeoxynucleotides protects against Entamoeba histolytica challenge.
    Ivory CP, Chadee K.
    Infect Immun; 2007 Oct; 75(10):4917-22. PubMed ID: 17620349
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 24.